Quick Answer
AYTU BIOPHARMA, INC reported Earnings Per Share Diluted of $5.11 (loss) per share for the year ending 2023.
- AYTU BIOPHARMA, INC showed an increase of +93.1% in Earnings Per Share Diluted from 2022 to 2023.
- This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on October 12, 2023.
- XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $0.35 (loss) per share | Q4 2020: $0.72 (loss) per share | Q1 2021: $1.41 (loss) per share | Q3 2021: $1.09 (loss) per share | Q4 2021: $8.74 (loss) per share | Q1 2022: $35.90 (loss) per share | Q3 2022: $0.28 (loss) per share | Q4 2022: $2.15 (loss) per share | Q1 2023: $1.93 (loss) per share | Q3 2023: $1.48 (loss) per share | Q4 2023: $0.04 (loss) per share | Q1 2024: $0.52 (loss) per share | Q3 2024: $0.15 (loss) per share | Q4 2024: $0.26 (loss) per share | Q1 2025: $0.21 per share | Q3 2025: $0.08 (loss) per share | Q4 2025: $1.05 (loss) per share.
- Over the full 3 years of available data (2021 to 2023), AYTU BIOPHARMA, INC's Earnings Per Share Diluted has declined by 46.8%.
- Historical annual values: Fiscal year 2023: $5.11 (loss) per share | Fiscal year 2022: $74.01 (loss) per share | Fiscal year 2021: $3.48 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: